“…A single nucleotide polymorphism (SNP) of CYP1A1 at position 3801 in the 3' untranslated region results in a change of a T to C base (Spurr et al, 1987). Consequently, this resulting MspI polymorphism has been extensively studied alongside numerous malignancies including cervical carcinoma, esophageal carcinoma, oral carcinoma, breast carcinoma, colorectal cancer and lung carcinoma (Sivaraman et al, 1994;Tanimoto et al, 1999;Kim et al, 2000;Goodman et al, 2001;Boyapati et al, 2005;Joseph et al, 2006;Agorastos et al, 2007;Juarez-Cedillo et al, 2007;Nishino et al, 2008;Gutman et al, 2009;Chen et al, 2011;von Keyserling et al, 2011;Sergentanis et al, 2012;Shukla et al, 2012;Zhuo et al, 2012a;Zhuo et al, 2012b;Ding et al, 2013;Islam et al, 2013;Liu et al, 2013;Saeed et al, 2013;Shukla et al, 2013;Xia et al, 2013;Yun et al, 2013;Jiang et al, 2014). The association between this CYP1A1 polymorphism with cervical carcinoma has been examined previously in various populations, with mixed results.…”